1. Scutellarin improves the radiosensitivity of non‐small cell lung cancer cells to iodine‐125 seeds via downregulating the AKT/mTOR pathway.
- Author
-
He, Guang‐hui, Xing, Dian‐jin, Jin, Die, Lu, Yue, Guo, Lei, Li, Yu‐liang, and Li, Dong
- Subjects
- *
LUNG cancer , *PROTEIN kinases , *FLOW cytometry , *IN vivo studies , *ANIMAL experimentation , *ANTINEOPLASTIC agents , *APOPTOSIS , *CELLULAR signal transduction , *GENE expression , *CELL cycle , *RADIATION-sensitizing agents , *FLAVONES , *CELL proliferation , *CELL lines , *IODINE , *MICE , *PHARMACODYNAMICS - Abstract
Background: In our previous study, we indicated that scutellarin (SCU) induced an anticancer effect in A549 cells. However, whether SCU regulates the radiosensitivity of non‐small cell lung cancer (NSCLC) and its related mechanism is still unclear. Methods: In this study, we explored the anticancer effect induced by iodine‐125 (125I) and SCU at a sensitizing concentration in A549 and H1975 cells. Cellular apoptosis and proliferation were detected by flow cytometry, Bcl‐2/Bax expression level, cell cycle, CCK‐8, and EdU staining. A tumor model using nude mice was also carried out to investigate the combined effect of 125I and SCU in vivo. In addition, the expression level of AKT/mTOR pathway was detected to investigate whether it is linked to the anticancer effect of 125I and SCU. Results: SCU at a sensitizing concentration promoted the 125I‐induced apoptosis and antiproliferative effect in A549 and H1975 cells. Moreover, the same results were obtained in vivo. Based on our findings, the AKT/mTOR pathway was significantly downregulated after combined treatment with 125I and SCU. Conclusions: The results of our study suggested that SCU promotes the anticancer effects induced by 125I in NSCLC cells by downregulating the AKT/mTOR pathway and lays a foundation for future application of this combined treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF